BY THE NUMBERS
$73.9B
Compiled by Cari Kraft, Jacobs Management Group, Inc.
Implantable medical devices market size in 2018 In a new report, Transparency Market Research has predicted that the implantable medical devices market will reach $73.9B by 2018, a CAGR expansion of 8.0% from 2012-2018. The market was $43.1B in 2011. Source: Transparency Market Research, “Implantable Medical Devices Market - U.S. Industry Analysis, Size, Share, Trends, Growth And Forecast 2012-2018”
1,826
Fewer pain med doses prescribed in states with medical marijuana laws Prescriptions of pain, anxiety, nausea and other medications have declined significantly in states where medical marijuana is legal. In a three year period, in the 17 states with a medical-marijuana law, prescriptions for painkillers fell by 1,826 doses, for anxiety by 562 doses, for nausea 541 doses, and declined for psychosis, seizures, sleep disorders and depression as well. Source: Bradford and Bradford, reported in Health Affairs, July 2016
COMMENT
45 | HS&M FEBRUARY/MARCH 2017
39% Share that brand manufacturers realize from gross drug expenditures Berkeley Research Group estimates that brand manufacturers get 39% of the money made on sales of their drugs. Of the rest, 42 percent goes to non-manufacturer entities such as supply chain companies, and others who realize rebates, discounts and fees. Source: Berkeley Research Group, “The Pharmaceutical Supply Chain: Gross Drug Expenditures Realized by Stakeholders,” 2017
36%
Percent of global clinical trials conducted in U.S. As of January 2017, over 85,000 clinical trials were being conducted in the U.S., about 36% of the world total of more than 235,000. Source: ClinicalTrials.gov, a service of the National Institutes of Health
